Supplemental experimental section
General information. All chemicals were commercial products of analytical grade and were used without further purification unless otherwise specified.
Universal polyethylene glycol (PEG) NovaTagTM resin (code: 855058, substitution: column (100 × 4.6 mm, 2.7 µm, flow rate = 1.2 mL/min), Grace Vision HT HL C18 column (150 × 4.6 mm, 3 µm, flow rate = 1.2 mL/min) or Agilent XDB C18 column (150 × 4.6 mm, 5 µm, flow rate = 0.6 mL/min). Compound purification was performed on Supelco Ascentis® C18 column (150 × 10 mm, 5 µm, flow rate = 3 mL/min). UV detection was performed at 230 nm, 280 nm or at the wavelength corresponding to the maximum of fluorochrome absorption. A solvent system consisting of (A) 0.1% trifluoroacetic acid (TFA) in water and (B) 0.09% TFA in acetonitrile was used.
Retention times (Rt) are reported in minutes. UV absorption and fluorescence measurements were performed on a UV-1800 spectrophotometer (Shimadzu, Kyoto Japan), and on Cary Eclipse apparatus (Varian, Palo Alto, CA), respectively. Mass spectrometry data were collected using a 4800 MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA) or an ESI ion trap Esquire HCT spectrometer (Bruker Daltonics, Billerica, MA). Amino acid compositions were characterized using an AminoTac JLC-500/V amino acid analyzer (JEOL, Tokyo, Japan). The identity and purity of each synthesized compound were assessed by NMR, analytical HPLC (two conditions of elution) and mass spectrometry. Fluorescence measurements were performed at room temperature. For each pseudo-peptide, the molar extinction coefficient was calculated from the absorbance value of a solution whose concentration was first determined by amino acid composition. Western blot analysis of MMP-2, -9, and -12 expression in sponge tissues harvested at day 1 and 4 after implantation. 
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